Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Percheron secures fresh funding to accelerate cancer therapy ambitions
April 14, 2026 - - Latest News -
Entropy advances psychedelic therapy trial as third patient achieves controlled response
April 14, 2026 - - Latest News -
Clarity expands manufacturing footprint as prostate cancer imaging agent nears market
April 14, 2026 - - Latest News -
Argent BioPharma advances epilepsy strategy with CannPal acquisition
April 13, 2026 - - Latest News -
Cartherics and Catalent deepen partnership to accelerate next generation cell therapies
April 13, 2026 - - AusBiotech -
Telix signs new cancer development deal with Regeneron
April 13, 2026 - - AusBiotech -
A decade of readiness as AVITA Medical expands burn response capability
April 9, 2026 - - Latest News